207 related articles for article (PubMed ID: 14519439)
1. Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes.
Chanalaris A; Lawrence KM; Stephanou A; Knight RD; Hsu SY; Hsueh AJ; Latchman DS
J Mol Cell Cardiol; 2003 Oct; 35(10):1295-305. PubMed ID: 14519439
[TBL] [Abstract][Full Text] [Related]
2. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
[TBL] [Abstract][Full Text] [Related]
3. Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death.
Brar BK; Stephanou A; Knight R; Latchman DS
J Mol Cell Cardiol; 2002 Apr; 34(4):483-92. PubMed ID: 11991736
[TBL] [Abstract][Full Text] [Related]
4. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.
Brar BK; Chen A; Perrin MH; Vale W
Endocrinology; 2004 Apr; 145(4):1718-29. PubMed ID: 14670995
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic effects of urocortin homologous peptides are mediated via activation of the Akt pathway.
Chanalaris A; Lawrence KM; Townsend PA; Davidson S; Jamshidi Y; Stephanou A; Knight RD; Hsu SY; Hsueh AJ; Latchman DS
Biochem Biophys Res Commun; 2005 Mar; 328(2):442-8. PubMed ID: 15694367
[TBL] [Abstract][Full Text] [Related]
6. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.
Chen A; Perrin M; Brar B; Li C; Jamieson P; Digruccio M; Lewis K; Vale W
Mol Endocrinol; 2005 Feb; 19(2):441-58. PubMed ID: 15514029
[TBL] [Abstract][Full Text] [Related]
7. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway.
Brar BK; Jonassen AK; Stephanou A; Santilli G; Railson J; Knight RA; Yellon DM; Latchman DS
J Biol Chem; 2000 Mar; 275(12):8508-14. PubMed ID: 10722688
[TBL] [Abstract][Full Text] [Related]
8. Urocortin protects against ischemic injury via a MAPK-dependent pathway.
Latchman DS
Trends Cardiovasc Med; 2001 Jul; 11(5):167-9. PubMed ID: 11597826
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors.
Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ
Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376
[TBL] [Abstract][Full Text] [Related]
10. Cardiotrophin-1 and urocortin cause protection by the same pathway and hypertrophy via distinct pathways in cardiac myocytes.
Railson JE; Liao Z; Brar BK; Buddle JC; Pennica D; Stephanou A; Latchman DS
Cytokine; 2002 Mar; 17(5):243-53. PubMed ID: 12027405
[TBL] [Abstract][Full Text] [Related]
11. SGK1 is involved in cardioprotection of urocortin-1 against hypoxia/reoxygenation in cardiomyocytes.
Cong B; Wang L; Zhu X; Li X; Liu B; Ni X
Can J Cardiol; 2014 Jun; 30(6):687-95. PubMed ID: 24882544
[TBL] [Abstract][Full Text] [Related]
12. Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta.
Kageyama K; Furukawa K; Miki I; Terui K; Motomura S; Suda T
J Cardiovasc Pharmacol; 2003 Oct; 42(4):561-5. PubMed ID: 14508243
[TBL] [Abstract][Full Text] [Related]
13. Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5'-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells.
Kageyama K; Suda T
Endocrinology; 2003 Jun; 144(6):2234-41. PubMed ID: 12746280
[TBL] [Abstract][Full Text] [Related]
14. Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility.
Karteris E; Hillhouse EW; Grammatopoulos D
Endocrinology; 2004 Feb; 145(2):890-900. PubMed ID: 14592950
[TBL] [Abstract][Full Text] [Related]
15. Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes.
Ikeda K; Tojo K; Sato S; Ebisawa T; Tokudome G; Hosoya T; Harada M; Nakagawa O; Nakao K
Biochem Biophys Res Commun; 1998 Sep; 250(2):298-304. PubMed ID: 9753624
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotection mediated by urocortin is dependent on PKCepsilon activation.
Lawrence KM; Kabir AM; Bellahcene M; Davidson S; Cao XB; McCormick J; Mesquita RA; Carroll CJ; Chanalaris A; Townsend PA; Hubank M; Stephanou A; Knight RA; Marber MS; Latchman DS
FASEB J; 2005 May; 19(7):831-3. PubMed ID: 15764590
[TBL] [Abstract][Full Text] [Related]
17. Ancient evolution of stress-regulating peptides in vertebrates.
Chang CL; Hsu SY
Peptides; 2004 Oct; 25(10):1681-8. PubMed ID: 15476935
[TBL] [Abstract][Full Text] [Related]
18. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins.
Grammatopoulos DK; Randeva HS; Levine MA; Katsanou ES; Hillhouse EW
Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536
[TBL] [Abstract][Full Text] [Related]
19. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein.
Mehrhof FB; Müller FU; Bergmann MW; Li P; Wang Y; Schmitz W; Dietz R; von Harsdorf R
Circulation; 2001 Oct; 104(17):2088-94. PubMed ID: 11673351
[TBL] [Abstract][Full Text] [Related]
20. Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway.
Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
Heart Vessels; 2012 Mar; 27(2):202-7. PubMed ID: 21505854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
